ACUTE AND LONG-TERM RESPONSE TO MK-421, A LONG-ACTING ORAL CONVERTING ENZYME-INHIBITOR, IN HEART-FAILURE

被引：0
作者：
LEVINE, TB [1 ]
OLIVARI, MT [1 ]
COHN, JN [1 ]
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
来源：
CIRCULATION | 1982年 / 66卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
[21]   LISINOPRIL AND CAPTOPRIL IN THE TREATMENT OF HEART-FAILURE IN OLDER PATIENTS - COMPARISON OF A LONG-ACTING AND SHORT-ACTING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR [J].
GILES, TD ;
FISHER, MB ;
RUSH, JE .
AMERICAN JOURNAL OF MEDICINE, 1988, 85 (3B) :44-47
[22]   HEMODYNAMIC AND CLINICAL-RESPONSE TO ENALAPRIL, A LONG-ACTING CONVERTING-ENZYME INHIBITOR, IN PATIENTS WITH CONGESTIVE HEART-FAILURE [J].
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
SHARKEY, SW ;
COHN, JN .
CIRCULATION, 1984, 69 (03) :548-553
[23]   DETERMINANTS OF ACUTE AND LONG-TERM RESPONSE TO CONVERTING ENZYME-INHIBITORS IN CONGESTIVE HEART-FAILURE [J].
LEVINE, TB ;
COHN, JN .
AMERICAN HEART JOURNAL, 1982, 104 (05) :1159-1164
[24]   THE ORAL CONVERTING ENZYME-INHIBITOR CAPTOPRIL IN HEART-FAILURE - ACUTE HEMODYNAMIC-EFFECTS, LONG-TERM TREATMENT, COMPARISON WITH PRAZOSIN (RALPH-READER PRIZE) [J].
SHARPE, DN ;
COXON, R ;
LONG, B .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (04) :452-452
[25]   EFFECT OF THE ANGIOTENSIN-I CONVERTING ENZYME-INHIBITOR, MK-421, ON EXPERIMENTALLY INDUCED DRINKING [J].
FREGLY, MJ ;
FATER, DC ;
GREENLEAF, JE .
APPETITE, 1982, 3 (04) :309-319
[26]   EFFECTS OF A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MK-421, IN NORMAL MEN AND PATIENTS [J].
KONO, T ;
OSEKO, F ;
IKEDA, F ;
NAKANO, R ;
TANIGUCHI, A ;
IMURA, H ;
ENDO, J .
ENDOCRINOLOGIA JAPONICA, 1982, 29 (05) :615-622
[27]   ANGIOTENSIN CONVERTING ENZYME-INHIBITION BY MK421 - A POTENT LONG-ACTING ORAL-AGENT [J].
JACKSON, B ;
JOHNSTON, CI .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1982, 12 (04) :362-362
[28]   A MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF BENAZEPRIL HYDROCHLORIDE, A LONG-ACTING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
INSEL, J ;
MIRVIS, DM ;
BOLAND, MJ ;
CINQUEGRANI, MP ;
SHANES, J ;
RUBIN, SA ;
WHALEN, JJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (03) :312-320
[29]   HEMODYNAMIC-RESPONSE TO CAPTOPRIL, AN ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CONGESTIVE HEART-FAILURE [J].
LEVINE, TB ;
COHN, JN ;
CARLYLE, PF ;
GROSS, KA .
CLINICAL RESEARCH, 1979, 27 (02) :A439-A439
[30]   ACUTE AND LONG-TERM EFFECTS OF THE NEW CONVERTING ENZYME-INHIBITOR MK 421 ON BLOOD-PRESSURE AND THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS [J].
KOLLOCH, R ;
STUMPE, KO ;
BAHNER, U ;
KRUCK, F .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (02) :20-20
12345